Cellectar Biosciences, Inc. 4
4 · Cellectar Biosciences, Inc. · Filed Jun 1, 2017
Insider Transaction Report
Form 4
NEIS JOHN
Director
Transactions
- Award
Stock option (right to buy)
2017-05-31+10,000→ 10,000 totalExercise: $1.74Exp: 2027-05-31→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Options vest in equal annual increments over a period of three years from the date of grant.